1. Who Should Be the Corresponding Author, What Are Their Responsibilities, and What Email Address Should They Provide?

   • Yochai Birnbaum
   • Masafumi Kitakaze
   • Barry F. Uretsky

   Editorial 14 July 2023 Pages: 1039 - 1040

2. CircCHMP5 Contributes to Ox-LDL-induced Endothelial Cell Injury Through the Regulation of MiR-532-5p/ROCK2 axis

   • Xia Li
   • Xiaoli Kang
   • Zheng Ji

   Original Article 27 January 2022 Pages: 1 - 12

   

3. Depletion of microRNA-92a Enhances the Role of Sevoflurane Treatment in Reducing Myocardial Ischemia–Reperfusion Injury by Upregulating KLF4

   • Qianfu Wu
   • Haihui Wang
   • Guoliang Yan

   Review Article 16 February 2022 Pages: 1053 - 1064

   

4. MicroRNA-30a-5p Promotes Chronic Heart Failure in Rats by Targeting Sirtuin-1 to Activate the Nuclear Factor-κB/NOD-Like Receptor 3 Signaling Pathway

   • Yu-Xian Wu
   • Rong-Yu Xu
   • Xiong-Jian Xiao

   Review Article 30 April 2022 Pages: 1065 - 1076

   

5. Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study

   • Pedro Garcia Brás
   • Tânia Branco Mano
   • Lídia de Sousa

   Original Article 17 June 2022 Pages: 1077 - 1086

   

6. Hyperglycemia-Induced Overexpression of PH Domain Leucine-Rich Repeat Protein Phosphatase 1 (PHLPP1) Compromises the Cardioprotective Effect of Ischemic Postconditioning Via Modulation of the Akt/Mst1 Pathway Signaling

   • Yun Qiu
   • Yuming Meng
   • Sumin Gao

   Original Article 18 June 2022 Pages: 1087 - 1101

   

7. Disulfiram protects against abdominal aortic aneurysm by ameliorating vascular smooth muscle cells pyroptosis

   • Fei Liao
   • Ling Wang
   • Jun Pu

   Original Article 20 June 2022 Pages: 1 - 14

   

8. Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation

   • Youzheng Dong
   • Zhenyu Zhai
   • Juxiang Li

   Original Article Open access 22 June 2022 Pages: 1117 - 1129

   

9. Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways

   • Yanghao Chen
   • Wante Lin
   • Gaojun Wu

   Orginal Article 24 June 2022 Pages: 1131 - 1141

   

10. Preventive Effect of Bone Marrow Mononuclear Cell Transplantation on Acute Myocardial Infarction-Induced Heart Failure: A Meta-analysis of Randomized Controlled Trials

    • Alireza Hosseinpour
    • Hamidreza Hosseinpour
    • Armin Attar

    Original Article 25 July 2022 Pages: 1143 - 1153

    

11. Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

    • Yuchao Zhang
    • Zheng Wu
    • Jinghua Liu

    Original Article Open access 05 August 2022 Pages: 1155 - 1166

    

12. A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease

    • Gurleen Kaur
    • Karan P. Desai
    • Mandeep S. Sidhu

    Review Article 14 January 2022 Pages: 1167 - 1174

    

13. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms

    • Tetsuji Miura
    • Tatsuya Sato
    • Keitaro Nishizawa

    Review Article 12 February 2022 Pages: 1175 - 1192

    

14. An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies

    • Jae-Sung Yi
    • Sravan Perla
    • Anton M. Bennett

    Review Article 14 February 2022 Pages: 1193 - 1204

    

15. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps

    • Jeffrey Triska
    • Juan Tamargo
    • Yochai Birnbaum

    Review Article 31 March 2022 Pages: 1205 - 1223

16. Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis

    • Kandavadivu Umashankar
    • Marco Mammi
    • Rania A. Mekary

    Review Article 25 April 2022 Pages: 1225 - 1237

    

17. Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial

    • Patrick Sulzgruber
    • Andreas Hammer
    • Alexander Niessner

    Short Communication Open access 14 June 2022 Pages: 1239 - 1241

18. The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients

    • Lisa Pool
    • Paul Knops
    • Natasja M. S. de Groot

    Trial Designs Open access 13 October 2022 Pages: 1243 - 1248